The Global Orthobiologics Market is expected to reach USD 10.2 billion by 2025, according to a new study by Hexa Reports. The orthobiologics market is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.
These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics market during the forecast period.
Browse Detail Report With TOC @ http://www.hexareports.com/report/orthobiologics-market
Further Key Findings From the Study Suggest:
In 2015, viscosupplementation accounted for the largest share in the product segment owing to being a cost efficient therapeutic alternative for symptomatic management of osteoarthritis
Spinal fusion held the largest share in the application segment in 2015, owing to presence of third party insurers and reimbursement structure for fusion enhancement products thus triggering growth
In 2015, North America accounted for the dominant share owing to consistent efforts of industry players in promoting awareness pertinent to the orthobiological products resulting in significant rise in adoption rate
Request A Sample copy of This Report @
Asia Pacific is anticipated to exhibit an exponential CAGR as a consequence of significant surge in healthcare spending and awareness levels with respect to the availability of orthobiologics
The prominent players are consistently indulging into extensive strategies to gain competitive position including regional expansion and mergers & acquisitions to capture a greater market share
For instance, in November 2015, Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This acquisition was carried out to expand orthobiologics product portfolio and grafting solutions in order to expand their market share
Browse More Biotechnology Related Market Research Reports:
• Next Generation Sequencing (NGS) Market Size & Forecast And Trend Analysis, 2014-2025 – http://www.hexareports.com/report/next-generation-sequencing-ngs-market
• Bone Morphogenetic Protein Market Analysis And Segment Forecasts, 2013-2024 – http://www.hexareports.com/report/bone-morphogenetic-protein-market
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
Email Us: firstname.lastname@example.org
Our Website: http://www.hexareports.com
Visit our Blog: http://hexareports.blogspot.com/